According to the recently released ICD-11, female sexual dysfunction can be a result of a lack of desire (hypoactive sexual desire dysfunction or HSDD), sexual arousal dysfunction, or orgasmic dysfunction
Featuring leading women’s health expert, Dr Terri Foran and a discussion panel of leading experts – Prof Deborah Bateson, Prof Rod Baber and Dr Lina Safro – this masterclass covers a wide range of information on the OCP.
Women who are obese and taking the combined oral contraceptive pill have 12 to 24 times greater risk of developing a leg-vein blood clot than those not taking the pill and who are not overweight, according to a recent review of research
In this Product Explainer, Endocrinologist Prof Susan Davis AO explains the role of topical testosterone for the treatment of hypoactive sexual desire dysfunction (HSDD) in postmenopausal women (4 mins).
In this Product Explainer, Sexual Health Physician Dr Terri Foran explains a first-of-its-kind contraceptive pill containing a unique estrogen – estetrol (E4) and progestin – drospirenone (DRSP) and describes its potential advantages (8 mins).
In this Product Explainer, Sexual Health Physician Dr Terri Foran explains estradiol and progesterone combined hormone therapy, the first and only body-identical combined treatment for post-menopausal women (6 mins).
Differences between combination vs progestogen-only pills, rules on missed and late pills, which pill to start with, what age to start, the risk with a family history of breast cancer, and applying the WHO’s “Medical Eligibility Criteria for Contraceptive Use” in practice